Vertex Pharmaceuticals
VRTX
VRTX
1,121 hedge funds and large institutions have $68.6B invested in Vertex Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 432 increasing their positions, 406 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% more repeat investments, than reductions
Existing positions increased: 432 | Existing positions reduced: 406
5% more capital invested
Capital invested by funds: $65.6B → $68.6B (+$2.99B)
2% more call options, than puts
Call options by funds: $445M | Put options by funds: $436M
Holders
1,121
Holding in Top 10
39
Calls
$445M
Puts
$436M
Top Buyers
| 1 | +$858M | |
| 2 | +$392M | |
| 3 | +$257M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$212M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$201M |
Top Sellers
| 1 | -$192M | |
| 2 | -$150M | |
| 3 | -$141M | |
| 4 |
JP Morgan Chase
New York
|
-$109M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$103M |